Form 10 Explorer
10-Q
Quarterly Report
VITASPRING BIOMEDICAL CO., LTD.

CIK: 1697884

File #: 333-216645

Period End: Jul 31, 2025

Fiscal Year: 2026

View on EDGAR
Balance Sheet
26 line items · 2 periods
XBRL
ItemJul 31, 2025Jan 31, 2025
BALANCE SHEETS
ASSETS
CURRENT ASSETS
Cash
799272
Other Non-Operating Current Assets
6,9250
Other Non-Operating Current Assets
1690
Total current assets
7,893272
LONG-TERM ASSET
Property, Plant and Equipment
9,12714,106
Total long-term asset
9,12714,106
Total assets
17,02014,378
LIABILITIES AND STOCKHOLDERS' DEFICIT
CURRENT LIABILITIES
Accounts payable - related party
2,411,0002,411,000
Accounts Payable
559,492494,751
Taxes Payable
336,094313,722
Advances from related party
917,020810,105
Total current liabilities
4,223,6064,029,578
Total liabilities
4,223,6064,029,578
COMMITMENTS AND CONTINGENCIES
00
STOCKHOLDERS' DEFICIT
Total Stockholders' Equity
20,70320,703
Total Stockholders' Equity
1,245,6001,245,600
Total Stockholders' Equity
(5,472,889)(5,281,503)
Total stockholders' deficit
(4,206,586)(4,015,200)
Total liabilities and stockholders' deficit
17,02014,378